Sarilumab Suppliers & Bulk Manufacturers
Available Forms: injection (prefilled syringe)
Available Strengths: 150 mg/1.14 mL, 200 mg/1.14 mL
Reference Brands: Kevzara (USA/EU)
Category: Immune Disorder
Sarilumab is a fully human monoclonal antibody that targets the interleukin‑6 (IL‑6) receptor (both membrane‑bound and soluble forms). By blocking IL‑6 from binding to its receptor, sarilumab inhibits the IL-6 mediated inflammatory signaling pathway. This reduces inflammation, immune‑mediated damage, and other symptoms associated with autoimmune inflammatory diseases such as rheumatoid arthritis and polymyalgia rheumatica. Sarilumab is available in injection (prefilled syringe) and strengths such as 150 mg/1.14 mL, 200 mg/1.14 mL. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Sarilumab is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Sarilumab can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Sarilumab is used to treat moderate to severe rheumatoid arthritis in adults who have not responded adequately to other disease-modifying antirheumatic drugs (DMARDs). It works as an interleukin-6 (IL-6) receptor antagonist, reducing inflammation and slowing joint damage.
Sarilumab is made from a human monoclonal antibody that specifically targets and blocks the IL-6 receptor, preventing the inflammatory effects of IL-6.
The trade name is Kevzara.
Kevzara is manufactured by Regeneron Pharmaceuticals in collaboration with Sanofi.
The generic name is sarilumab.
The primary brand name is Kevzara.
It is manufactured in approved biopharmaceutical facilities in the USA and Europe.
Related Products
Quick Response Guaranteed | Verified Suppliers
